Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 471

1.

The Genetic Links to Anxiety and Depression (GLAD) Study: Online recruitment into the largest recontactable study of depression and anxiety.

Davies MR, Kalsi G, Armour C, Jones IR, McIntosh AM, Smith DJ, Walters JTR, Bradley JR, Kingston N, Ashford S, Beange I, Brailean A, Cleare AJ, Coleman JRI, Curtis CJ, Curzons SCB, Davis KAS, Dowey LRC, Gault VA, Goldsmith KA, Bennett MH, Hirose Y, Hotopf M, Hübel C, Kanz C, Leng J, Lyall DM, Mason BD, McAtarsney-Kovacs M, Monssen D, Moulton A, Ovington N, Palaiologou E, Pariante CM, Parikh S, Peel AJ, Price RK, Rimes KA, Rogers HC, Sambrook J, Skelton M, Spaul A, Suarez ELA, Sykes BL, Thomas KG, Young AH, Vassos E, Veale D, White KM, Wingrove J; NIHR BioResource consortium, Eley TC, Breen G.

Behav Res Ther. 2019 Dec;123:103503. doi: 10.1016/j.brat.2019.103503. Epub 2019 Oct 24.

PMID:
31715324
2.

Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders.

Andlauer TFM, Guzman-Parra J, Streit F, Strohmaier J, González MJ, Gil Flores S, Cabaleiro Fabeiro FJ, Del Río Noriega F, Perez FP, Haro González J, Orozco Diaz G, de Diego-Otero Y, Moreno-Küstner B, Auburger G, Degenhardt F, Heilmann-Heimbach S, Herms S, Hoffmann P, Frank J, Foo JC, Treutlein J, Witt SH, Cichon S, Kogevinas M; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Rivas F, Mayoral F, Müller-Myhsok B, Forstner AJ, Nöthen MM, Rietschel M.

Mol Psychiatry. 2019 Nov 11. doi: 10.1038/s41380-019-0558-2. [Epub ahead of print]

PMID:
31712721
3.

Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts.

Figaro-Drumond FV, Pereira SC, Menezes IC, von Werne Baes C, Coeli-Lacchini FB, Oliveira-Paula GH, Cleare AJ, Young AH, Tanus-Santos JE, Juruena MF, Lacchini R.

Behav Brain Res. 2019 Nov 5:112343. doi: 10.1016/j.bbr.2019.112343. [Epub ahead of print]

PMID:
31704233
4.

Esketamine and the Need for a New Type of Registry for Drugs With Abuse Potential.

McShane R, Baldwin DS, McAllister-Williams RH, Stone JM, Taylor D, Winstock AR, Young AH.

Am J Psychiatry. 2019 Nov 1;176(11):966. doi: 10.1176/appi.ajp.2019.19060631. No abstract available.

PMID:
31672039
5.

Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes.

Fornaro M, Maritan E, Ferranti R, Zaninotto L, Miola A, Anastasia A, Murru A, Solé E, Stubbs B, Carvalho AF, Serretti A, Vieta E, Fusar-Poli P, McGuire P, Young AH, Dazzan P, Vigod SN, Correll CU, Solmi M.

Am J Psychiatry. 2019 Oct 18:appiajp201919030228. doi: 10.1176/appi.ajp.2019.19030228. [Epub ahead of print]

PMID:
31623458
6.

Cognitive enhancement interventions for people with bipolar disorder: A systematic review of methodological quality, treatment approaches, and outcomes.

Tsapekos D, Seccomandi B, Mantingh T, Cella M, Wykes T, Young AH.

Bipolar Disord. 2019 Oct 14. doi: 10.1111/bdi.12848. [Epub ahead of print] Review.

PMID:
31610086
7.

Chronotherapy for the rapid treatment of depression: A meta-analysis.

Humpston C, Benedetti F, Serfaty M, Markham S, Hodsoll J, Young AH, Veale D.

J Affect Disord. 2019 Sep 30;261:91-102. doi: 10.1016/j.jad.2019.09.078. [Epub ahead of print] Review.

PMID:
31606606
8.

"Do depressive and manic symptoms differentially impact on functioning in acute depression? Results from a large, cross-sectional study".

Anmella G, Gil-Badenes J, Pacchiarotti I, Verdolini N, Aedo A, Angst J, Azorin JM, Bowden CL, Mosolov S, Samalin L, Popovic D, Young AH, Perugi G, Vieta E, Murru A.

J Affect Disord. 2019 Oct 1;261:30-39. doi: 10.1016/j.jad.2019.09.070. [Epub ahead of print]

PMID:
31600585
9.

Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review.

Dragioti E, Solmi M, Favaro A, Fusar-Poli P, Dazzan P, Thompson T, Stubbs B, Firth J, Fornaro M, Tsartsalis D, Carvalho AF, Vieta E, McGuire P, Young AH, Shin JI, Correll CU, Evangelou E.

JAMA Psychiatry. 2019 Oct 2. doi: 10.1001/jamapsychiatry.2019.2859. [Epub ahead of print]

PMID:
31577342
10.

Promotion of Wellbeing for Children of Parents With Mental Illness: A Model Protocol for Research and Intervention.

Reedtz C, van Doesum K, Signorini G, Lauritzen C, van Amelsvoort T, van Santvoort F, Young AH, Conus P, Musil R, Schulze T, Berk M, Stringaris A, Piché G, de Girolamo G.

Front Psychiatry. 2019 Sep 6;10:606. doi: 10.3389/fpsyt.2019.00606. eCollection 2019.

11.

Lithium: past, present, and future.

Cousins DA, Squarcina L, Boumezbeur F, Young AH, Bellivier F.

Lancet Psychiatry. 2019 Sep 26. pii: S2215-0366(19)30365-7. doi: 10.1016/S2215-0366(19)30365-7. [Epub ahead of print] No abstract available.

PMID:
31564465
12.

First episode mania: we should have intervened earlier.

Jauhar S, Ratheesh A, Davey C, Yatham LN, McGorry PD, McGuire P, Berk M, Young AH.

Lancet Psychiatry. 2019 Oct;6(10):807-808. doi: 10.1016/S2215-0366(19)30340-2. No abstract available.

PMID:
31544759
13.

Blame-rebalance fMRI neurofeedback in major depressive disorder: A randomised proof-of-concept trial.

Zahn R, Weingartner JH, Basilio R, Bado P, Mattos P, Sato JR, de Oliveira-Souza R, Fontenelle LF, Young AH, Moll J.

Neuroimage Clin. 2019 Aug 25;24:101992. doi: 10.1016/j.nicl.2019.101992. [Epub ahead of print]

14.

Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis.

Lombardo G, Enache D, Gianotti L, Schatzberg AF, Young AH, Pariante CM, Mondelli V.

Psychoneuroendocrinology. 2019 Dec;110:104420. doi: 10.1016/j.psyneuen.2019.104420. Epub 2019 Aug 23.

PMID:
31499391
15.

Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force.

Miskowiak KW, Seeberg I, Kjaerstad HL, Burdick KE, Martinez-Aran A, Del Mar Bonnin C, Bowie CR, Carvalho AF, Gallagher P, Hasler G, Lafer B, López-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, Porter RJ, Purdon S, Torres IJ, Yatham LN, Young AH, Kessing LV, Van Rheenen TE, Vieta E.

Bipolar Disord. 2019 Sep 6. doi: 10.1111/bdi.12834. [Epub ahead of print] Review.

PMID:
31491048
16.

The Chimera of Circular Insanity and the labours of Thyreoidea.

Qureshi MM, Young AH.

Bipolar Disord. 2019 Sep 6. doi: 10.1111/bdi.12833. [Epub ahead of print]

PMID:
31491040
17.

The role of different patterns of psychomotor symptoms in major depressive episode: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts.

Barbuti M, Mainardi C, Pacchiarotti I, Verdolini N, Maccariello G, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Vieta E, Perugi G.

Bipolar Disord. 2019 Aug 10. doi: 10.1111/bdi.12816. [Epub ahead of print]

PMID:
31400256
18.

Authors' reply.

Wahba M, Sousa S, Watson S, Strawbridge R, Young AH, Lingford-Hughes A.

Br J Psychiatry. 2019 Sep;215(3):568-569. doi: 10.1192/bjp.2019.171. No abstract available.

PMID:
31397248
19.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data.

Romagnoni A, Jégou S, Van Steen K, Wainrib G, Hugot JP; International Inflammatory Bowel Disease Genetics Consortium (IIBDGC).

Sci Rep. 2019 Jul 17;9(1):10351. doi: 10.1038/s41598-019-46649-z.

20.

Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospects.

Agustini B, Bocharova M, Walker AJ, Berk M, Young AH, Juruena MF.

J Affect Disord. 2019 Sep 1;256:584-593. doi: 10.1016/j.jad.2019.06.060. Epub 2019 Jul 2. Review.

PMID:
31299439
21.

Gut feeling: randomized controlled trials of probiotics for the treatment of clinical depression: Systematic review and meta-analysis.

Nikolova V, Zaidi SY, Young AH, Cleare AJ, Stone JM.

Ther Adv Psychopharmacol. 2019 Jun 26;9:2045125319859963. doi: 10.1177/2045125319859963. eCollection 2019. Review.

22.

The case for improved care and provision of treatment for people with first-episode mania.

Jauhar S, Ratheesh A, Davey C, Yatham LN, McGorry PD, McGuire P, Berk M, Young AH.

Lancet Psychiatry. 2019 Oct;6(10):869-876. doi: 10.1016/S2215-0366(19)30082-3. Epub 2019 Jun 24. Review.

PMID:
31248840
23.

Tapering of SSRI treatment to mitigate withdrawal symptoms.

Selvaraj S, Jauhar S, Baldwin DS, Cowen PJ, Goodwin G, Hayes JF, Nutt DJ, Veronese M, Young AH.

Lancet Psychiatry. 2019 Jul;6(7):560-561. doi: 10.1016/S2215-0366(19)30183-X. No abstract available.

PMID:
31230676
24.

Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis.

Perugi G, Pacchiarotti I, Mainardi C, Verdolini N, Menculini G, Barbuti M, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Vieta E; BRIDGE-II-MIX Study Group.

Eur Neuropsychopharmacol. 2019 Jul;29(7):825-834. doi: 10.1016/j.euroneuro.2019.06.001. Epub 2019 Jun 18.

PMID:
31227264
25.

Relationships between recurrence and polarity in major depressive disorders: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts.

Barbuti M, Mazzarini L, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G; BRIDGE-II-Mix Study Group.

J Affect Disord. 2019 Sep 1;256:250-258. doi: 10.1016/j.jad.2019.06.005. Epub 2019 Jun 4.

PMID:
31195243
26.

Depression in the Primary Care Setting.

Moulton CD, Young AH.

N Engl J Med. 2019 Jun 6;380(23):2278. doi: 10.1056/NEJMc1903259. No abstract available.

PMID:
31167070
27.

The role of overlapping excitatory symptoms in major depression: are they relevant for the diagnosis of mixed state?

Brancati GE, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G; BRIDGE–II–Mix Study Group.

J Psychiatr Res. 2019 Aug;115:151-157. doi: 10.1016/j.jpsychires.2019.05.014. Epub 2019 May 14.

PMID:
31132693
28.

Uncovering neurodevelopmental features in bipolar affective disorder.

Valli I, Fabbri C, Young AH.

Br J Psychiatry. 2019 Jul;215(1):383-385. doi: 10.1192/bjp.2019.117. Epub 2019 May 22.

PMID:
31113507
29.

What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium.

Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E, Kupka RW, Zarate C, Nielsen RE, Baldessarini RJ, Severus E; ISBD/IGSLI Task Force on the treatment with lithium.

Bipolar Disord. 2019 Aug;21(5):394-409. doi: 10.1111/bdi.12805. Epub 2019 Jun 20. Review.

30.

Genome-wide association study identifies 30 loci associated with bipolar disorder.

Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, Pers TH, Holmans PA, Richards AL, Abbott L, Agerbo E, Akil H, Albani D, Alliey-Rodriguez N, Als TD, Anjorin A, Antilla V, Awasthi S, Badner JA, Bækvad-Hansen M, Barchas JD, Bass N, Bauer M, Belliveau R, Bergen SE, Pedersen CB, Bøen E, Boks MP, Boocock J, Budde M, Bunney W, Burmeister M, Bybjerg-Grauholm J, Byerley W, Casas M, Cerrato F, Cervantes P, Chambert K, Charney AW, Chen D, Churchhouse C, Clarke TK, Coryell W, Craig DW, Cruceanu C, Curtis D, Czerski PM, Dale AM, de Jong S, Degenhardt F, Del-Favero J, DePaulo JR, Djurovic S, Dobbyn AL, Dumont A, Elvsåshagen T, Escott-Price V, Fan CC, Fischer SB, Flickinger M, Foroud TM, Forty L, Frank J, Fraser C, Freimer NB, Frisén L, Gade K, Gage D, Garnham J, Giambartolomei C, Pedersen MG, Goldstein J, Gordon SD, Gordon-Smith K, Green EK, Green MJ, Greenwood TA, Grove J, Guan W, Guzman-Parra J, Hamshere ML, Hautzinger M, Heilbronner U, Herms S, Hipolito M, Hoffmann P, Holland D, Huckins L, Jamain S, Johnson JS, Juréus A, Kandaswamy R, Karlsson R, Kennedy JL, Kittel-Schneider S, Knowles JA, Kogevinas M, Koller AC, Kupka R, Lavebratt C, Lawrence J, Lawson WB, Leber M, Lee PH, Levy SE, Li JZ, Liu C, Lucae S, Maaser A, MacIntyre DJ, Mahon PB, Maier W, Martinsson L, McCarroll S, McGuffin P, McInnis MG, McKay JD, Medeiros H, Medland SE, Meng F, Milani L, Montgomery GW, Morris DW, Mühleisen TW, Mullins N, Nguyen H, Nievergelt CM, Adolfsson AN, Nwulia EA, O'Donovan C, Loohuis LMO, Ori APS, Oruc L, Ösby U, Perlis RH, Perry A, Pfennig A, Potash JB, Purcell SM, Regeer EJ, Reif A, Reinbold CS, Rice JP, Rivas F, Rivera M, Roussos P, Ruderfer DM, Ryu E, Sánchez-Mora C, Schatzberg AF, Scheftner WA, Schork NJ, Shannon Weickert C, Shehktman T, Shilling PD, Sigurdsson E, Slaney C, Smeland OB, Sobell JL, Søholm Hansen C, Spijker AT, St Clair D, Steffens M, Strauss JS, Streit F, Strohmaier J, Szelinger S, Thompson RC, Thorgeirsson TE, Treutlein J, Vedder H, Wang W, Watson SJ, Weickert TW, Witt SH, Xi S, Xu W, Young AH, Zandi P, Zhang P, Zöllner S; eQTLGen Consortium; BIOS Consortium, Adolfsson R, Agartz I, Alda M, Backlund L, Baune BT, Bellivier F, Berrettini WH, Biernacka JM, Blackwood DHR, Boehnke M, Børglum AD, Corvin A, Craddock N, Daly MJ, Dannlowski U, Esko T, Etain B, Frye M, Fullerton JM, Gershon ES, Gill M, Goes F, Grigoroiu-Serbanescu M, Hauser J, Hougaard DM, Hultman CM, Jones I, Jones LA, Kahn RS, Kirov G, Landén M, Leboyer M, Lewis CM, Li QS, Lissowska J, Martin NG, Mayoral F, McElroy SL, McIntosh AM, McMahon FJ, Melle I, Metspalu A, Mitchell PB, Morken G, Mors O, Mortensen PB, Müller-Myhsok B, Myers RM, Neale BM, Nimgaonkar V, Nordentoft M, Nöthen MM, O'Donovan MC, Oedegaard KJ, Owen MJ, Paciga SA, Pato C, Pato MT, Posthuma D, Ramos-Quiroga JA, Ribasés M, Rietschel M, Rouleau GA, Schalling M, Schofield PR, Schulze TG, Serretti A, Smoller JW, Stefansson H, Stefansson K, Stordal E, Sullivan PF, Turecki G, Vaaler AE, Vieta E, Vincent JB, Werge T, Nurnberger JI, Wray NR, Di Florio A, Edenberg HJ, Cichon S, Ophoff RA, Scott LJ, Andreassen OA, Kelsoe J, Sklar P; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium.

Nat Genet. 2019 May;51(5):793-803. doi: 10.1038/s41588-019-0397-8. Epub 2019 May 1.

PMID:
31043756
31.

Genetic Overlap Between Alzheimer's Disease and Bipolar Disorder Implicates the MARK2 and VAC14 Genes.

Drange OK, Smeland OB, Shadrin AA, Finseth PI, Witoelar A, Frei O; Psychiatric Genomics Consortium Bipolar Disorder Working Group, Wang Y, Hassani S, Djurovic S, Dale AM, Andreassen OA.

Front Neurosci. 2019 Mar 13;13:220. doi: 10.3389/fnins.2019.00220. eCollection 2019.

32.
33.

Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy.

Jauhar S, Young AH.

Int J Bipolar Disord. 2019 Mar 27;7(1):10. doi: 10.1186/s40345-019-0145-0. Review.

34.

Dehydroepiandrosterone and cortisol as markers of HPA axis dysregulation in women with low sexual desire.

Basson R, O'Loughlin JI, Weinberg J, Young AH, Bodnar T, Brotto LA.

Psychoneuroendocrinology. 2019 Jun;104:259-268. doi: 10.1016/j.psyneuen.2019.03.001. Epub 2019 Mar 8.

PMID:
30909007
35.

Inflammation, Glutamate, and Cognition in Bipolar Disorder Type II: A Proof of Concept Study.

King S, Jelen LA, Horne CM, Cleare A, Pariante CM, Young AH, Stone JM.

Front Psychiatry. 2019 Mar 1;10:66. doi: 10.3389/fpsyt.2019.00066. eCollection 2019.

36.

A systematic review on neuropsychological function in bipolar disorders type I and II and subthreshold bipolar disorders-something to think about.

King S, Stone JM, Cleare A, Young AH.

CNS Spectr. 2019 Feb;24(1):127-143. doi: 10.1017/S1092852918001463.

PMID:
30859934
37.

The implications of hypersomnia in the context of major depression: Results from a large, international, observational study.

Murru A, Guiso G, Barbuti M, Anmella G, Verdolini N, Samalin L, Azorin JM, Angst JJ, Bowden CL, Mosolov S, Young AH, Popovic D, Valdes M, Perugi G, Vieta E, Pacchiarotti I; BRIDGE-II-Mix Study Group.

Eur Neuropsychopharmacol. 2019 Apr;29(4):471-481. doi: 10.1016/j.euroneuro.2019.02.011. Epub 2019 Mar 4.

PMID:
30846287
38.

Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition - CORRIGENDUM.

Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Di Florio A, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, Hamish McAllister-Williams R, Morriss R, Nayrouz S, Pappa S, Soares JC, Smith DJ, Suppes T, Talbot P, Vieta E, Watson S, Yatham LN, Young AH, Stokes PRA.

Br J Psychiatry. 2019 May;214(5):309. doi: 10.1192/bjp.2019.36. Epub 2019 Feb 28. No abstract available.

PMID:
30816078
39.

Sultans of Swing: A Reappraisal of the Intertwined Association Between Affective Lability and Mood Reactivity in a Post Hoc Analysis of the BRIDGE-II-MIX Study.

Verdolini N, Menculini G, Perugi G, Murru A, Samalin L, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Barbuti M, Popovic D, Vieta E, Pacchiarotti I; BRIDGE-II-MIX Study Group.

J Clin Psychiatry. 2019 Feb 19;80(2). pii: 17m12082. doi: 10.4088/JCP.17m12082.

PMID:
30786180
40.

Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial.

Husain MI, Chaudhry IB, Khoso AB, Husain MO, Rahman RR, Hamirani MM, Hodsoll J, Carvalho AF, Husain N, Young AH.

BJPsych Open. 2019 Jan;5(1):e13. doi: 10.1192/bjo.2018.84.

41.

Associations between childhood maltreatment and inflammatory markers.

Palmos AB, Watson S, Hughes T, Finkelmeyer A, McAllister-Williams RH, Ferrier N, Anderson IM, Nair R, Young AH, Strawbridge R, Cleare AJ, Chung R, Frissa S, Goodwin L, Hotopf M, Hatch SL, Wang H, Collier DA, Thuret S, Breen G, Powell TR.

BJPsych Open. 2019 Jan;5(1):e3. doi: 10.1192/bjo.2018.80.

42.

Tamoxifen for bipolar disorder: Systematic review and meta-analysis.

Palacios J, Yildiz A, Young AH, Taylor MJ.

J Psychopharmacol. 2019 Feb;33(2):177-184. doi: 10.1177/0269881118822167. Epub 2019 Feb 11.

PMID:
30741085
43.

Brain activation during human defensive behaviour: A systematic review and preliminary meta-analysis.

Patrick F, Kempton MJ, Marwood L, Williams SCR, Young AH, Perkins AM.

Neurosci Biobehav Rev. 2019 Mar;98:71-84. doi: 10.1016/j.neubiorev.2018.12.028. Epub 2019 Jan 3.

PMID:
30611801
44.

Modulation of anterior cingulate cortex reward and penalty signalling in medication-naive young-adult subjects with depressive symptoms following acute dose lurasidone.

Wolke SA, Mehta MA, O'Daly O, Zelaya F, Zahreddine N, Keren H, O'Callaghan G, Young AH, Leibenluft E, Pine DS, Stringaris A.

Psychol Med. 2019 Jun;49(8):1365-1377. doi: 10.1017/S0033291718003306. Epub 2019 Jan 4.

45.

The relationship between attention deficit hyperactivity disorder, bipolarity and mixed features in major depressive patients: Evidence from the BRIDGE-II-Mix Study.

Vannucchi G, Medda P, Pallucchini A, Bertelli M, Angst J, Azorin JM, Bowden C, Vieta E, Young AH, Mosolov S, Perugi G; BRIDGE-II-Mix Study Group.

J Affect Disord. 2019 Mar 1;246:346-354. doi: 10.1016/j.jad.2018.12.089. Epub 2018 Dec 25.

PMID:
30597295
46.

Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis - CORRIGENDUM.

Strawbridge R, Carter B, Marwood L, Bandelow B, Tsapekos D, Nikolova VL, Taylor R, Mantingh T, de Angel V, Patrick F, Cleare AJ, Young AH.

Br J Psychiatry. 2018 Dec 19:1. doi: 10.1192/bjp.2018.291. [Epub ahead of print] No abstract available.

PMID:
30566398
47.

Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.

Jelen LA, King S, Horne CM, Lythgoe DJ, Young AH, Stone JM.

Eur Neuropsychopharmacol. 2019 Dec;29(2):222-234. doi: 10.1016/j.euroneuro.2018.12.005. Epub 2018 Dec 14.

PMID:
30558824
48.

Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.

Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Florio AD, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, McAllister-Williams RH, Morriss R, Nayrouz S, Pappa S, Soares JC, Smith DJ, Suppes T, Talbot P, Vieta E, Watson S, Yatham LN, Young AH, Stokes PRA.

Br J Psychiatry. 2019 Jan;214(1):27-35. doi: 10.1192/bjp.2018.257. Epub 2018 Dec 6. Erratum in: Br J Psychiatry. 2019 May;214(5):309.

PMID:
30520709
49.

Multiple-therapy-resistant major depressive disorder: a clinically important concept.

McAllister-Williams RH, Christmas DMB, Cleare AJ, Currie A, Gledhill J, Insole L, Malizia AL, McGeever M, Morriss R, Robinson LJ, Scott M, Stokes PRA, Talbot PS, Young AH.

Br J Psychiatry. 2018 May;212(5):274-278. doi: 10.1192/bjp.2017.33.

PMID:
30517072
50.

Psychiatry foretold.

Hidalgo-Mazzei D, Young AH.

Aust N Z J Psychiatry. 2019 Apr;53(4):365-366. doi: 10.1177/0004867418816821. Epub 2018 Dec 4. No abstract available.

PMID:
30514099

Supplemental Content

Loading ...
Support Center